dc.contributor.author | Jabbari, M | |
dc.contributor.author | Kheirouri, S | |
dc.contributor.author | Alizadeh, M | |
dc.date.accessioned | 2018-08-26T08:51:22Z | |
dc.date.available | 2018-08-26T08:51:22Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53366 | |
dc.description.abstract | Objective We aimed to investigate the association between serum levels of ghrelin and brain-derived neurotrophic factor (BDNF) with MetS and its components in premenopausal women. Methods 43 patients with MetS and 43 healthy controls participated in this study. Participants' body mass index (BMI), waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) were measured. Serum levels of total cholesterol (TC), triglyceride (TG), low and high density lipoprotein cholesterol (LDL-C and HDL-C), fasting blood sugar (FBS), insulin, BDNF and ghrelin determined. Homeostasis model assessment insulin resistance index (HOMA-IR) was also calculated. Results Participants in MetS group had higher waist-to-hip ratios, elevated SBP and DBP, and higher serum levels of TG, FBS and insulin when compared with the control group. Serum ghrelin and BDNF levels were significantly lower in participants with MetS than in the healthier control subjects. There was a strong, positive correlation between serum ghrelin and BDNF levels. Both proteins negatively correlated with TG, FBS, HOMA-IR and positively with HDL-C. Furthermore, serum BDNF levels negatively associated with insulin levels. Conclusions The findings indicate that variations occur in the circulating level of ghrelin and BDNF proteins in MetS patients. A strong correlation between serum ghrelin and BDNF suggests that production, release or practice of these 2 proteins might be related mechanically. é American Society for Clinical Pathology 2018. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Lab Medicine | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | ghrelin | |
dc.subject | glucose | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | insulin | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | triacylglycerol | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | brain-derived neurotrophic factor, human | |
dc.subject | ghrelin | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | body mass | |
dc.subject | cholesterol blood level | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | diastolic blood pressure | |
dc.subject | disease association | |
dc.subject | female | |
dc.subject | glucose blood level | |
dc.subject | homeostasis model assessment | |
dc.subject | hormone blood level | |
dc.subject | human | |
dc.subject | insulin blood level | |
dc.subject | metabolic syndrome X | |
dc.subject | premenopause | |
dc.subject | protein blood level | |
dc.subject | systolic blood pressure | |
dc.subject | triacylglycerol blood level | |
dc.subject | waist circumference | |
dc.subject | waist hip ratio | |
dc.subject | blood | |
dc.subject | case control study | |
dc.subject | metabolic syndrome X | |
dc.subject | middle aged | |
dc.subject | premenopause | |
dc.subject | Adult | |
dc.subject | Brain-Derived Neurotrophic Factor | |
dc.subject | Case-Control Studies | |
dc.subject | Female | |
dc.subject | Ghrelin | |
dc.subject | Humans | |
dc.subject | Metabolic Syndrome | |
dc.subject | Middle Aged | |
dc.subject | Premenopause | |
dc.title | Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women with Metabolic Syndrome | |
dc.type | Article | |
dc.citation.volume | 49 | |
dc.citation.issue | 2 | |
dc.citation.spage | 140 | |
dc.citation.epage | 146 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1093/labmed/lmx087 | |